Phase I dose-finding and pharmacologic study of cisplatin (P), irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors

被引：0
|
作者：
Enzinger, Peter C. [1 ]
Earle, Craig [1 ]
Zhu, Andrew [1 ]
Blaskowsky, Lawrence [1 ]
Kulke, Matthew [1 ]
Ryan, David [1 ]
Langford, Lauren [1 ]
Michelini, Ann [1 ]
Meyerhardt, Jeffrey [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Partners Canc Care, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [21] PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Contouriotis, A. M.
    Law, C. N. J.
    Soria, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 157
  • [22] A PHASE I DOSE-FINDING STUDY OF VORINOSTAT (V) COMBINED WITH CAPECITABINE (X) AND CISPLATIN (P) AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Yoo, C.
    Ryu, M. H.
    Ryoo, B.
    Koo, D. H.
    Park, I.
    Kang, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 234 - 234
  • [23] A phase I dose-finding study of vorinostat (V) combined with capecitabine (X) and cisplatin (P) as first-line therapy in patients with advanced gastric cancer
    Yoo, Changhoon
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Koo, Dong Hoe
    Park, Inkeun
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [24] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [25] Phase I dose-finding and pharmacokinetic study of a combination of elisidepsin (E) and erlotinib (T) in patients (pts) with advanced solid tumors.
    Goel, Sanjay
    Moran, Teresa
    Coronado, Cinthya
    Ramirez, Santiago Viteri
    Chaudhary, Imran
    Ghalib, Mohammad Haroon
    Swami, Umang
    Hou, Yijuan
    Carcereny, Enric
    Alcantara, Jose
    Dios, Jorge Luis Iglesias
    De Miguel, Bernardo
    Buges, Cristina
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
    Poveda, Andres
    Oaknin, Ana
    Romero, Ignacio
    Guerrero-Zotano, Angel
    Farinas-Madrid, Lorena
    Rodriguez-Freixinos, Victor
    Mallol, Pedro
    Lopez-Reig, Raquel
    Antonio Lopez-Guerrero, Jose
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
    Andres Poveda
    Ana Oaknin
    Ignacio Romero
    Angel Guerrero-Zotano
    Lorena Fariñas-Madrid
    Victor Rodriguez-Freixinos
    Pedro Mallol
    Raquel Lopez-Reig
    Jose Antonio Lopez-Guerrero
    Scientific Reports, 11
  • [28] Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Weiss, J
    Ferrier, A
    Vukovic, V
    Weitman, S
    Richards, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 223S - 223S
  • [29] Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Fornier, M. N.
    Rathkopf, D.
    Shah, M.
    Patil, S.
    O'Reilly, E.
    Tse, A. N.
    Hudis, C.
    Lefkowitz, R.
    Kelsen, D. P.
    Schwartz, G. K.
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5841 - 5846
  • [30] A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours
    Sastre, J
    Paz-Ares, L
    Carcas, A
    Alfonso, R
    Grávalos, C
    Frias, J
    Guerra, P
    Pronk, L
    Cortes-Funes, H
    Diaz-Rubio, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 453 - 460
12345